Tonix Pharmaceuticals Holding Corp (TNXP)
EBITDA
-$157.54M
TTM · Period ending: · USD
TNXP EBITDA
Latest reported-$157.54Mperiod ending
Latest reported-$157.54Mperiod ending
TNXP EBITDA (-$21.13K → -$157.54M)
Annual EBITDA
High-resolution chart · PNG
TNXP ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -122,007,000 | |
| -74,323,000 | |
| -112,367,000 | |
| -108,965,000 | |
| -92,237,000 | |
| -50,436,000 | |
| -28,802,000 | |
| -26,268,000 | |
| -21,221,000 | |
| -38,763,000 | |
| -48,001,000 | |
| -27,620,000 | |
| -10,871,000 | |
| -6,645,206 | |
| -3,369,228 | |
| -1,924,834 | |
| -30,866 | |
| -21,134 |